Thalassaemia Intermedia: an Update
Author Information
Author(s): Ali T. Taher, Khaled M. Musallam, Maria D. Cappellini
Primary Institution: American University of Beirut Medical Centre
Conclusion
Our understanding of thalassaemia intermedia has significantly improved, but clear treatment guidelines are still lacking.
Supporting Evidence
- Thalassaemia intermedia patients can experience complications unique to their condition.
- Management options include transfusion therapy and iron chelation.
- Pulmonary hypertension is prevalent in thalassaemia intermedia patients.
Takeaway
Thalassaemia intermedia is a blood disorder that can cause various health problems, and while we know more about it now, we still need better treatment plans.
Methodology
This review summarizes molecular and clinical characteristics of thalassaemia intermedia and discusses current treatment options.
Limitations
There are no clear guidelines for optimal management of thalassaemia intermedia.
Participant Demographics
The study included 8860 thalassaemia patients, with 2190 having thalassaemia intermedia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website